Northern Trust Corp Sangamo Therapeutics, Inc Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

A detailed history of Northern Trust Corp transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Northern Trust Corp holds 381,240 shares of SGMO stock, worth $743,418. This represents 0.0% of its overall portfolio holdings.

Number of Shares
381,240
Previous 1,201,047 68.26%
Holding current value
$743,418
Previous $432,000 24.31%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$0.32 - $1.1 $262,338 - $901,787
-819,807 Reduced 68.26%
381,240 $327,000
Q2 2024

Aug 14, 2024
SELL
$0.36 - $0.65 $10,021 - $18,094
-27,838 Reduced 2.27%
1,201,047 $432,000
Q1 2024

May 14, 2024
SELL
$0.42 - $1.38 $15,931 - $52,344
-37,931 Reduced 2.99%
1,228,885 $823,000
Q4 2023

Feb 13, 2024
BUY
$0.3 - $0.63 $23,060 - $48,427
76,869 Added 6.46%
1,266,816 $684,000
Q3 2023

Nov 13, 2023
SELL
$0.58 - $1.47 $6,972 - $17,672
-12,022 Reduced 1.0%
1,189,947 $713,000
Q2 2023

Aug 11, 2023
SELL
$1.11 - $1.74 $51,109 - $80,118
-46,045 Reduced 3.69%
1,201,969 $1.56 Million
Q1 2023

May 15, 2023
SELL
$1.66 - $3.67 $64,987 - $143,676
-39,149 Reduced 3.04%
1,248,014 $2.2 Million
Q4 2022

Feb 13, 2023
BUY
$2.77 - $5.07 $202,104 - $369,917
72,962 Added 6.01%
1,287,163 $4.04 Million
Q3 2022

Nov 14, 2022
BUY
$4.27 - $6.39 $206,539 - $309,084
48,370 Added 4.15%
1,214,201 $5.95 Million
Q2 2022

Aug 12, 2022
SELL
$3.28 - $6.21 $109,574 - $207,457
-33,407 Reduced 2.79%
1,165,831 $4.83 Million
Q1 2022

May 13, 2022
SELL
$5.23 - $7.82 $197,840 - $295,814
-37,828 Reduced 3.06%
1,199,238 $6.97 Million
Q4 2021

Feb 08, 2022
SELL
$7.29 - $10.97 $1.59 Million - $2.39 Million
-217,931 Reduced 14.98%
1,237,066 $9.28 Million
Q3 2021

Nov 15, 2021
SELL
$9.01 - $12.01 $328,369 - $437,704
-36,445 Reduced 2.44%
1,454,997 $13.1 Million
Q2 2021

Aug 13, 2021
BUY
$10.17 - $12.64 $1.46 Million - $1.81 Million
143,240 Added 10.62%
1,491,442 $17.9 Million
Q1 2021

May 12, 2021
SELL
$10.88 - $17.05 $1 Million - $1.57 Million
-92,118 Reduced 6.4%
1,348,202 $16.9 Million
Q4 2020

Feb 11, 2021
SELL
$9.23 - $18.18 $458,066 - $902,237
-49,628 Reduced 3.33%
1,440,320 $22.5 Million
Q3 2020

Nov 16, 2020
SELL
$9.38 - $12.48 $793,163 - $1.06 Million
-84,559 Reduced 5.37%
1,489,948 $14.1 Million
Q2 2020

Aug 14, 2020
BUY
$6.21 - $11.83 $754,297 - $1.44 Million
121,465 Added 8.36%
1,574,507 $14.1 Million
Q1 2020

May 14, 2020
SELL
$5.05 - $8.85 $260,403 - $456,350
-51,565 Reduced 3.43%
1,453,042 $9.26 Million
Q4 2019

Feb 14, 2020
SELL
$8.03 - $11.7 $81,303 - $118,462
-10,125 Reduced 0.67%
1,504,607 $12.6 Million
Q3 2019

Nov 13, 2019
BUY
$9.05 - $12.22 $1.28 Million - $1.73 Million
141,263 Added 10.29%
1,514,732 $13.7 Million
Q2 2019

Aug 13, 2019
BUY
$8.75 - $13.03 $447,448 - $666,315
51,137 Added 3.87%
1,373,469 $14.8 Million
Q1 2019

May 13, 2019
BUY
$7.72 - $12.81 $6,338 - $10,517
821 Added 0.06%
1,322,332 $12.6 Million
Q4 2018

Feb 12, 2019
SELL
$9.51 - $16.6 $13,837 - $24,153
-1,455 Reduced 0.11%
1,321,511 $15.2 Million
Q3 2018

Nov 14, 2018
BUY
$13.05 - $19.05 $458,916 - $669,912
35,166 Added 2.73%
1,322,966 $22.4 Million
Q2 2018

Sep 18, 2018
SELL
$13.9 - $19.8 $69,791 - $99,415
-5,021 Reduced 0.39%
1,287,800 $18.3 Million
Q2 2018

Aug 14, 2018
BUY
$13.9 - $19.8 $3.18 Million - $4.53 Million
228,891 Added 21.51%
1,292,821 $18.4 Million
Q1 2018

May 09, 2018
BUY
$16.7 - $26.35 $50,066 - $78,997
2,998 Added 0.28%
1,063,930 $20.2 Million
Q4 2017

Feb 14, 2018
SELL
$11.6 - $17.35 $94,690 - $141,628
-8,163 Reduced 0.76%
1,060,932 $17.4 Million
Q3 2017

Nov 13, 2017
BUY
$8.4 - $15.0 $8.98 Million - $16 Million
1,069,095
1,069,095 $16 Million

Others Institutions Holding SGMO

# of Institutions
115
Shares Held
56.4M
Call Options Held
576K
Put Options Held
1.17M
View Full List

About SANGAMO THERAPEUTICS, INC

SGMO Quotes by TradingView
  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $305M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email